– Plenary Speaker-
Jordi Vila is the Head of the Department of Clinical Microbiology of the Hospital Clinic, Professor of the School of Medicine, University of Barcelona, and Research Professor in the Institute for Global Health (ISGlobal), Barcelona Spain. His research is focused on the molecular basis of antimicrobial resistance as well as development of new drugs against MDR bacteria and molecular tools for rapid diagnosis. He was the Programme Director of the Congress of ESCMID (2009 to 2014) and he has been the president of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (2019-2021). He has published more than 484 articles and three patents.
Robin Patel is the Elizabeth P. and Robert E. Allen Professor of Individualized Medicine and the Director of the Infectious Diseases Research Laboratory, Co-Director of the Clinical Bacteriology Laboratory, Vice Chair of Education in the Department of Laboratory Medicine and Pathology, and former Chair of the Division of Clinical Microbiology, at the Mayo Clinic.
Since the beginning of her tenure at the Mayo Clinic, Dr. Patel has focused her research on bacterial infections. Her work focuses on three major areas: (1) improvement of next-generation diagnostic techniques, (2) understanding the inherent biology of periprosthetic infection, and (3) understanding antibiotic resistance through a clinical lens. She has published over 500 peer-reviewed publications and is supported by the National Institutes of Health, the Department of Defense, the National Science Foundation, and the Centers for Disease Control and Prevention. She is the Director of the Laboratory Center of the Antibacterial Resistance Leadership Group of the National Institutes of Health.
Dr. Patel received an undergraduate degree in Chemistry from Princeton University, where she graduated magna cum laude. From there, she obtained a medical degree from McGill University. Afterwards, Dr. Patel completed Internal Medicine Residency and Fellowships in Medical Microbiology and Infectious Diseases at the Mayo Clinic. Since then, she has been involved in setting standards for diagnostic and clinical care of bacterial infections, as evidenced by the (select) positions she has held or holds within the American Society for Microbiology (President), American Board of Pathology (Microbiology Test Writing Committee Member), Clinical and Laboratory Standards Institute (Subcommittee on Antimicrobial Susceptibility Testing Voting Member), National Institutes of Allergy and Infectious Diseases (Council Member), National Board of Medical Examiners (Microbiology/Immunology Test Material Development Committee Chair), Journal of Clinical Microbiology (Associate Editor), and Clinical Infectious Diseases (Associate Editor).
In addition, Dr. Patel’s continued commitment to mentorship can be translated into a long list of trainees from around the world; she had dedicated hours of teaching to train the next generation of scientists and MDs.
More information can be found at: https://journals.asm.org/doi/full/10.1128/JCM.01259-20.
Patrice Nordmann is currently Head of the Molecular and Medical Microbology , Dept Medicine, University of Fribourg (Switzerland) and director of the Reference Center for Emerging Antibiotic Resistance. He is co-author of more than 800 peer-reviewed publications mostly on biochemistry, genetics and epidemiology of emerging antibiotic resistance in Gram negatives (IF =58). He has taken several patents in Diagnostic Microbiology. He has been the recipient of several awards including the Medaille Louis Pasteur from the French National Academy of Sciences, Paris, and the Excellence Microbiology and Infectious Diseases award from the European Society for Microbiology and Infectious Diseases, Berlin, and of the American Society for Microbiology in San Diego.
Amalio Telenti, MD PhD
Chief data scientist and SVP bioinformatics at Vir. He was previously a professor of genomics at Scripps Research, La Jolla CA. Earlier, we was chief scientific officer at Human Longevity, Inc. His expertise is in host and pathogen genomics and in data science in medicine. Amalio Telenti is a highly cited researcher: his work received over 60,000 citations. He is an elected member of the Swiss Academy of Medical Sciences and member of the scientific boards of the Institute Pasteur Shanghai at the Chinese Academy of Sciences, the Swiss Personalized Health Network, Caris Life Sciences, Bitmark Inc. and nFerence Inc. He is recipient of the Swiss Cloetta award in Medicine for his work in HIV and tuberculosis. Education: MD, University of Oviedo, Spain; PhD, University of Zaragoza, Spain; Residency in internal medicine and in infectious diseases, Mayo Clinic, Rochester MN; Postdoctoral fellow, microbiology, University of Bern, Switzerland.
Bert Niesters (1958) is full professor and director of the Laboratory of Clinical Virology at the University Medical Center and University of Groningen, the Netherlands. He has been actively involved in the implementation and development of molecular technologies in clinical virology. Recently, his interest focused on rapid regional epidemiology (REGIOTYPE), MiddleWare solutions (FlowG), as well as the cost-benefit of point-of-impact molecular testing. Special interest is on raising awareness for the detection of enteroviruses D68 and its relationship with acute flaccid myelitis (AFM). Since 2017, he is the chair of the executive board of QCMD (Glasgow). He is a lead-auditor and technical assessor for the Dutch Council of Accreditation (ISO15189, ISO22870) and adviser to the expert panel for medical devices by the European Commission. He serves as Co-Editor-in-Chief for the Journal of Clinical Virology. He is an (co)-author of 250+ papers, chapters, and reviews. For his entire work, he received in 2016 the “Ed Nowakowski Senior Memorial Clinical Virology Award” from the Pan American Society for Clinical Virology.
Ana Alastruey-Izquierdo is as a Research Scientist in the Mycology Reference Laboratory at the Spanish National Centre for Microbiology (ISCIII, Madrid, Spain). Her main area of research is focused in medical mycology: diagnostics, treatment, antifungal resistance and public health. She chairs the expert group of the Fungal priority Pathogens list by WHO, is the chair of the EFISG Study group from ESCMID, vicepresident of the Asociacion Española de Micologia (partner of European Confedereation of Medical Mycology), the director of Latin-American programs for GAFFI (Global Action Fund for Fungal infections) and has published 150 scientific works including several guidelines.
Martí Vall-Mayans is Faculty Specialist and Senior Researcher at the STI and Skin NTD Unit of the Department of Infectious Diseases and Fight AIDS and Infectious Diseases Foundation, Hospital Germans Trias Pujol , Badalona, Catalonia (Spain). Former WHO Consultant, he is member of the editorial board of the IUSTI-Europe guidelines and past Scientific Chair of the 2020 European IUSTI congress. His clinical and research interests include the implementation of alternative treatments and strategies for treponemal and skin neglected tropical diseases.
José Luis del Pozo
Director of the Infectious Diseases Division and the Microbiology Division of the Clínica Universidad de Navarra. Full Professor at the School of Medicine of the University of Navarra. Fellowship (2006-2009) in the Division of Infectious Diseases of Mayo Clinic College of Medicine in Rochester, Minnesota (USA). Author of more than 130 publications in journals indexed in PubMed. Co-author of more than 20 book chapters. Author/co-author of more than 200 communications to national and international congresses. More than 200 invited lectures in National and International Congresses, Seminars and Conferences. Participation in 10 Research Projects as Principal Investigator and in 11 as member of the research team. Principal Investigator of the Institute of Health Research of Navarra. Established Researcher of the Institute of Health Research La Fe of Valencia. President of the Infectious Diseases Commission of my hospital. Until June 2021 President of the Board of Directors of the Hospital Infection Study Group (GEIRAS-SEIMC) in Spain.
José Miguel Cisneros Herreros
Head of the Infectious Diseases Department at the Hospital Universitario Virgen del Rocío, Sevilla . Past-President of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) 2017-2019. Past-Director of the PIRASOA programme (2013-2021). He is principal investigator of 18 national and international research projects. Author of more than 230 scientific articles on antimicrobials, bacterial resistance, healthcare associated infections and antimicrobial stewardship programmes